Development of an explainable AI system using routine clinical parameters for rapid differentiation of inflammatory conditions

• DOI: 10.3389/fimmu.2024.1364954
• Publication Date: 2024-03-06T04:25:52Z
• Authors: Joerg Hoffmann; Anne Rheude; Andreas Neubauer; Cornelia Brendel; Michael C. Thrun
• Keywords: ddc:610; CD64 ; explainable AI ; infection ; CD169 ; inflammation; 0303 health sciences; Immunology; Medizin; 610; Graft vs Host Disease; Bacterial Infections; RC581-607; Medical sciences Medicine; infection; explainable AI; Autoimmune Diseases; 03 medical and health sciences; inflammation; Artificial Intelligence; Virus Diseases; CD169; Humans; CD64; ddc:610; Immunologic diseases. Allergy

IntroductionInflammatory conditions in patients have various causes and require different treatments. Bacterial infections are treated with antibiotics, while these medications are ineffective against viral infections. Autoimmune diseases and graft-versus-host disease (GVHD) after allogeneic stem cell transplantation, require immunosuppressive therapies such as glucocorticoids, which may be contraindicated in other inflammatory states. In this study, we employ a combination of straightforward blood tests to devise an explainable artificial intelligence (XAI) for distinguishing between bacterial infections, viral infections, and autoimmune diseases/graft-versus-host disease.Patients and methodsWe analysed peripheral blood from 80 patients with inflammatory conditions and 38 controls. Complete blood count, CRP analysis, and a rapid flow cytometric test for myeloid activation markers CD169, CD64, and HLA-DR were utilized. A two-step XAI distinguished firstly with C5.0 rules pruned by ABC analysis between controls and inflammatory conditions and secondly between the types of inflammatory conditions with a new bivariate decision tree using the Simpson impurity function.ResultsInflammatory conditions were distinguished using an XAI, achieving an overall accuracy of 81.0% (95%CI 72 – 87%). Bacterial infection (N = 30), viral infection (N = 26), and autoimmune diseases/GVHD (N = 24) were differentiated with accuracies of 90.3%, 80.0%, and 79.0%, respectively. The most critical parameter for distinguishing between controls and inflammatory conditions was the expression of CD64 on neutrophils. Monocyte count and expression of CD169 were most crucial for the classification within the inflammatory conditions.ConclusionTreatment decisions for inflammatory conditions can be effectively guided by XAI rules, straightforward to implement and based on promptly acquired blood parameters.